Crewe Advisors LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

Back to all holdings Add to watchlist

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Crewe Advisors LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$325,573
-18.8%
59,7380.0%0.06%0.0%
Q2 2023$400,842
-24.0%
59,7380.0%0.06%
-27.3%
Q1 2023$527,487
+15.6%
59,7380.0%0.08%
+6.9%
Q4 2022$456,398
+7.1%
59,738
-0.2%
0.07%
-6.5%
Q3 2022$426,000
-12.0%
59,8510.0%0.08%
-28.0%
Q2 2022$484,000
-41.1%
59,851
+1.0%
0.11%
-33.1%
Q1 2022$822,000
-50.5%
59,238
+0.2%
0.16%
-52.5%
Q4 2021$1,659,000
-17.5%
59,1380.0%0.34%
-29.1%
Q3 2021$2,010,000
-16.8%
59,1380.0%0.48%
-20.7%
Q2 2021$2,416,000
+1.5%
59,1380.0%0.60%
+1.4%
Q1 2021$2,381,000
-31.9%
59,1380.0%0.59%
-57.8%
Q4 2020$3,497,000
-5.4%
59,138
-22.2%
1.40%
-19.3%
Q3 2020$3,696,000
-6.2%
76,008
-6.6%
1.73%
-9.9%
Q2 2020$3,939,000
+52.4%
81,418
-12.5%
1.92%
+24.8%
Q1 2020$2,584,000–93,000–1.54%–
 Download
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders